ALERT: COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patient’s protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine visits are available for routine office visits.

All Patients – Very Important: Regardless of vaccination status.  If you are experiencing a fever or cold-like like symptoms, which also include GI Symptoms and Diarrhea, you should contact your Virginia Cancer Specialists Advice Line before visiting our clinics for scheduled appointments. This includes symptoms of respiratory illness, such as coughing or difficulty breathing.  More Information-PLEASE CLICK HERE

Archive

Post Archive: Clinical Trials and Research

Virginia Cancer Specialists » Practice News » Clinical Trials and Research

Virginia Cancer Specialists Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

October 11, 2021
Read More

Next Oncology Expands Phase I Program with Virginia Cancer Specialists Partnership

October 6, 2021
Read More

Virginia Cancer Specialists Joins MYLUNG Consortium, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

February 4, 2021
Read More

Alex Spira, MD PhD FACP VCS Co-Author Virginia Cancer Specialists - JAMA Network - Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas Clinical Trial

April 9, 2020
Read More

MMRC MyDrug Clinical Trial - Myeloma-Developing Regimens Using Genomics

June 26, 2019
Read More

New Treatments, New Hope for Bladder Cancer Patients at Virginia Cancer Specialists – Dr. Daniel Chong, MD

May 9, 2019
Read More

Fighting Brain Cancer at Virginia Cancer Specialists VCS:  Better Options, Better Outcomes -  Timothy A. McCarthy, MD

April 30, 2019
Read More

Virginia Cancer Specialists (VCS) Now Offering a Newly FDA-Approved Targeted Therapy for Acute Leukemia

February 4, 2019
Read More

Announcing the upcoming opening of the MMRC MyDRUG clinical trial, which will enroll patients with recurrent Multiple Myeloma

December 12, 2018
Read More

Lung Cancer and Clinical Trial News, Alex Spira, M.D., PhD, F.A.C.P.

November 26, 2018
Read More